Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists
Published
Related content
- Update on MDMA and psilocybin access and safeguards from 1 July 2023Stay updated about the commencement of MDMA and psilocybin for the treatment of certain mental illnesses.
- Understanding the changes to MDMA and psilocybin accessFrom 1 July 2023, authorised psychiatrists can prescribe psychedelic medicines to people with specific mental health conditions under strict controls.
- Removal of prescribing restrictions on ivermectinFrom 1 June 2023, prescribing of oral ivermectin for ‘off-label’ uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists.